Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2904622 | 1.00 | TRPA1 (0.54) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL16269804 | 1.00 | TRPA1 (0.54) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL5878109 | 1.00 | TRPA1 (0.54) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL4163177 | 1.00 | TRPA1 (0.54) | TRPA1CYP1A2EPHX1TSHRALPI | |
| Bicarbonate SCHEMBL17044690 | 0.94 | CYP1A2 (0.52) | TRPA1CYP1A2EPHX1ALPIPKM | |
| SCHEMBL108646 | 0.90 | TRPA1 (0.58) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL537721 | 0.86 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL29189650 | 0.86 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL3418072 | 0.86 | TRPA1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI | |
| SCHEMBL30304201 | 0.85 | TDP1 (0.50) | TRPA1CYP1A2EPHX1TSHRALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12396941-B2 | Cosmetic composition that resists pilling | L'OREAL (FR) | 2025-08-26 | — | — | US | claimed |
| US-12303576-B2 | Two phase water-based smudge-resistant make-up remover | L'OREAL (FR) | 2025-05-20 | — | — | US | claimed |
| US-11819559-B2 | Cosmetic compositions comprising an antimicrobial system with reduced eye irritation or discomfort | L'OREAL (FR) | 2023-11-21 | — | — | US | claimed |
| EP-4221665-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | L'OREAL (FR) | 2023-08-09 | — | — | EP | claimed |
| CN-116367810-A | Cosmetic composition comprising an antimicrobial system for reducing eye irritation or discomfort | 欧莱雅 | 2023-06-30 | — | — | CN | claimed |
| US-11679072-B2 | Water-based smudge-resistant make-up remover | L'OREAL (FR) | 2023-06-20 | — | — | US | claimed |
| WO-2022072585-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | L'OREAL (FR) | 2022-04-07 | — | — | WO | claimed |
| US-20220096345-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | L'OREAL (FR) | 2022-03-31 | — | — | US | claimed |
| US-20220062150-A1 | WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVER | L'OREAL (FR) | 2022-03-03 | — | — | US | claimed |
| WO-2022047179-A1 | WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVER | L'OREAL (FR) | 2022-03-03 | — | — | WO | claimed |
| US-8398762-B2 | Pigmented inkjet ink comprising a bleed control agent | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-19 | — | — | US | claimed |
| WO-2010111343-A1 | PIGMENTED INKJET INK COMPRISING A BLEED CONTROL AGENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-09-30 | — | — | WO | claimed |
| EP-1238649-B1 | Hair dye compositions comprising acidic dyes and lactones | KAO CORP (JP) | 2008-01-09 | — | — | EP | claimed |
| US-6776803-B2 | Hair dye compositions | KAO CORPORATION (JP) | 2004-08-17 | — | — | US | claimed |
| US-20030066141-A1 | Hair dye compositions | KAO CORPORATION (JP) | 2003-04-10 | — | — | US | claimed |
| EP-1238649-A2 | Hair dye compositions | Kao Corporation (JP) | 2002-09-11 | — | — | EP | claimed |
| US-6248314-B1 | Hair dye composition having a particular buffer capacity and containing an alkylene carbonate | KAO CORPORATION (JP) | 2001-06-19 | — | — | US | claimed |
| US-6206935-B1 | APPLYING BLEACHING AGENTS AND DIRECT DYE | KAO CORPORATION (JP) | 2001-03-27 | — | — | US | claimed |
| EP-1022014-A1 | Hair dye composition | Kao Corporation (JP) | 2000-07-26 | — | — | EP | claimed |
| US-4181545-A | POT LIFE OF HYDROXY POLYBUTADIENE | UNITED TECHNOLOGIES CORPORATION (US) | 1980-01-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096345-A1 | COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT | GK, PIR, LAGE3 | TRPA1 132/4885CYP1A2 1464/4885EPHX1 1596/4885 |
| US-11819559-B2 | Cosmetic compositions comprising an antimicrobial system with reduced eye irritation or discomfort | GK, PIR, LAGE3 | TRPA1 132/4885CYP1A2 1464/4885EPHX1 1596/4885 |
| US-20030066141-A1 | Hair dye compositions | HAAO, SRD5A1, GLA | TRPA1 839/4885CYP1A2 552/4885EPHX1 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.